D-0786-2021 Class II Terminated
FDA drug recall D-0786-2021 was initiated by Akorn, Inc. on Aug 2, 2021 and is designated Class II. Reason for recall: Non-Sterility - OOS sterility testing observed during 12-month controlled room temperature stability testing. The microbiological investigation identified the organism as a member of the Bacillus… The recall status is terminated (terminated Aug 22, 2022). Affected quantity: 142,188 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 8, 2021
- Initiation Date
- Aug 2, 2021
- Termination Date
- Aug 22, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 142,188 tubes
Product description
Artificial Tears Ointment, Lubricant Eye Ointment, Net Wt. 3.5 g (1/8 oz.) per tube, Sterile, Manufactured by: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-062-35
Reason for recall
Non-Sterility - OOS sterility testing observed during 12-month controlled room temperature stability testing. The microbiological investigation identified the organism as a member of the Bacillus cereus group.
Distribution pattern
Nationwide USA and Puerto Rico
Code information
Lot #: 9G01A, Exp 06/2022; 9H32A, Exp 07/2022; 9K82A, 9K82B, Exp 09/2022
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0786-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026